Global Stock News

ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

Article feature image

ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

PORTLAND, Maine, July 07, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (ImmuCell or the Company), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health…

Click here to view the original article.

Share this article

Scroll to Top